Potential protection from toxicity by oral iron chelators

被引：41
|
作者：
Hider, RC
机构：
[1] Department of Pharmacy, King's College London, London, SW3 6LX, Manresa Road
来源：
TOXICOLOGY LETTERS | 1995年 / 82-3卷
关键词：
iron chelators; oral activity; metalloenzymes; hydroxypyridinones; cell cycle;
D O I：
10.1016/0378-4274(95)03606-7
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The design of clinically useful iron chelators requires attention to be paid to 3 key parameters: oral absorption, selectivity and affinity for iron(III) and toxicity. Factors which influence these 3 parameters are discussed. Hydroxypyridinones are identified as key ligands and properties leading to minimal toxicity and optimum distribution for the treatment of thalassaemia are presented. Key metalloenzymes which are inhibited by iron chelators are identified.
引用
收藏
页码：961 / 967
页数：7
相关论文
共 50 条
  • [41] Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity
    Raymond J. Bergeron
    Jan Wiegand
    Neelam Bharti
    James S. McManis
    Shailendra Singh
    BioMetals, 2011, 24 : 239 - 258
  • [42] Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants
    Gutbier, Simon
    Kyriakou, Sotiris
    Schildknecht, Stefan
    Ueckert, Anna-Katharina
    Bruell, Markus
    Lewis, Frank
    Dickens, David
    Pearson, Liam
    Elson, Joanna L.
    Michel, Sylvia
    Hubscher-Bruder, Vronique
    Brandel, Jeremy
    Tetard, David
    Leist, Marcel
    Pienaar, Ilse S.
    ARCHIVES OF TOXICOLOGY, 2020, 94 (09) : 3105 - 3123
  • [43] EFFECTS OF IRON, COPPER, COBALT, AND THEIR CHELATORS ON THE CYTO-TOXICITY OF BLEOMYCIN
    LIN, PS
    KWOCK, L
    HEFTER, K
    MISSLBECK, G
    CANCER RESEARCH, 1983, 43 (03) : 1049 - 1053
  • [44] PROTECTIVE EFFECT OF IRON CHELATORS ON EPIRUBICIN-INDUCED FIBROBLAST TOXICITY
    HENRIKSSON, R
    GRANKVIST, K
    CANCER LETTERS, 1988, 43 (03) : 179 - 183
  • [45] Potential fluoride toxicity from oral medicaments: A review
    Ullah, Rizwan
    Zafar, Muhammad Sohail
    Shahani, Nazish
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 20 (08) : 841 - 848
  • [46] Iron Chelators for the treatment of iron overload disease: Relationship between structure, redox activity, and toxicity
    Chaston, TB
    Richardson, DR
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 200 - 210
  • [47] Therapeutic Potential of Iron Chelators in Viral Diseases: A Systematic Review
    Lori, Maryam Shamseddini
    Khandani, Azade Kalantari
    Dehghannoudeh, Gholamreza
    Ohadi, Mandana
    Ansari, Mehdi
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (27) : 4383 - 4391
  • [48] Therapeutic potential of synthetic and natural iron chelators against ferroptosis
    Prabhune, Nupura Manish
    Ameen, Bilal
    Prabhu, Sudharshan
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
  • [49] Synthetic and natural iron chelators: therapeutic potential and clinical use
    Hatcher, Heather C.
    Singh, Ravi N.
    Torti, Frank M.
    Torti, Suzy V.
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (09) : 1643 - 1670
  • [50] Iron chelators as drugs against malaria pose a potential risk
    Golenser, J
    Domb, A
    Leshem, B
    Kremsner, P
    Luty, A
    REDOX REPORT, 2003, 8 (05) : 268 - 271
12345